Jakafi Tablet
RxNorm Crosswalk NDC 50881-005

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

The product Jakafi (NDC 50881-005) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 20 unique RxNorm concepts. By anchoring Incyte Corporation's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCDPrescribable
Featured Concept

ruxolitinib 10 MG Oral Tablet
(RxCUI 1193331)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Jakafi 10 MG Oral Tablet
(RxCUI 1193337)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

ruxolitinib 5 MG Oral Tablet
(RxCUI 1193339)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Jakafi 5 MG Oral Tablet
(RxCUI 1193341)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

ruxolitinib 15 MG Oral Tablet
(RxCUI 1193343)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Jakafi 15 MG Oral Tablet
(RxCUI 1193345)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

ruxolitinib 20 MG Oral Tablet
(RxCUI 1193347)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Jakafi 20 MG Oral Tablet
(RxCUI 1193349)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

ruxolitinib 25 MG Oral Tablet
(RxCUI 1193351)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Jakafi 25 MG Oral Tablet
(RxCUI 1193353)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCD
Featured Concept

24 HR ruxolitinib 11 MG Extended Release Oral Tablet
(RxCUI 2743012)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSN
Featured Concept

Jakafi XR 11 MG 24HR Extended Release Oral Tablet
(RxCUI 2743016)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCD
Featured Concept

24 HR ruxolitinib 22 MG Extended Release Oral Tablet
(RxCUI 2743019)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSN
Featured Concept

Jakafi XR 22 MG 24HR Extended Release Oral Tablet
(RxCUI 2743022)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCD
Featured Concept

24 HR ruxolitinib 33 MG Extended Release Oral Tablet
(RxCUI 2743025)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSN
Featured Concept

Jakafi XR 33 MG 24HR Extended Release Oral Tablet
(RxCUI 2743028)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCD
Featured Concept

24 HR ruxolitinib 44 MG Extended Release Oral Tablet
(RxCUI 2743032)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSN
Featured Concept

Jakafi XR 44 MG 24HR Extended Release Oral Tablet
(RxCUI 2743035)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCD
Featured Concept

24 HR ruxolitinib 55 MG Extended Release Oral Tablet
(RxCUI 2743041)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSN
Featured Concept

Jakafi XR 55 MG 24HR Extended Release Oral Tablet
(RxCUI 2743044)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Understanding RxNorm Mapping for Jakafi

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 50881-005 to RxCUI 1193331, 1193337, 1193339, 1193341, 1193343, 1193345, 1193347, 1193349, 1193351, 1193353, 2743012, 2743016, 2743019, 2743022, 2743025, 2743028, 2743032, 2743035, 2743041, 2743044, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.

* Please review the full disclaimer at the bottom of this page.